Nano Mask Retains FDA Medical Consulting Firm AlvaMed to Seek FDA Approval for NanoMask(TM)
* Reuters is not responsible for the content in this press release.
MANTECA, CA, Oct 05 (MARKET WIRE) --
Nano Mask Inc (PINKSHEETS: NANM) today announced that it has retained
AlvaMed LLC, an FDA consulting firm specializing in medical devices, to
prepare the company's latest generation disposable, anti-viral NanoMask
for FDA approval.
"We are looking forward to working with AlvaMed's experienced team to
assist us to obtain FDA approval in a timely manner," said Doug Heath, CEO
of Nano Mask. "We are confident that AlvaMed will help us successfully
navigate the FDA approval process -- including all necessary testing and
application submission -- to obtain the regulatory approval necessary to
enable the company to maximize its marketing efforts in the .so United
States."
Separately, Nano Mask announced the appointment of David M. Mierkey as
Director of Marketing. Previously, Mr. Mierkey was a partner at the
Treetop Marketing Group (TMG) and the Ken Group which provide Strategic
Market Planning, Key Account Management, Sales & Marketing Leadership,
Retail Merchandising, New Business Development, Vendor Negotiations, Sales
Training & Development, Product Incentives & Promotions, New Product
Introduction and Customer Driven Management to a variety of industries.
Prior to the TMG, he was the V.P. of Sales for Emergency Filtration
Products, Inc. where he had direct management responsibility for all the
Sales and Marketing.
Mr. Mierkey was also employed by Nova Information Services, a division of
U.S. Bank, where he was V.P./Western Regional Manager, directing a
multi-billion dollar payment processing company and had the responsibility
to establish marketing and selling strategies for the forty western
states. Challenged to plan and orchestrate an aggressive market expansion
for the Community Bank Division, Mr. Mierkey successfully built business
relationships with a 750-bank/branch network that involved referral, agent
and processing institutions. The scope of his responsibilities included
strategic planning, competitive assessment, market positioning, business
development, new product introductions and client relationship management.
"I am happy to have David join our team," Doug Heath said. "I worked with
David when I operated 2HD distributors, which marketed the early NanoMask,
and was impressed with his enthusiasm and marketing knowledge. David has a
valuable knowledge of our product and our target market, which he gained
from his previous tenure with our company."
Mr. Heath added, "Nano Mask has been making good progress. With the
surging demand for masks due to the swine flu outbreak, Nano Mask has
accelerated its efforts to develop a safe, effective NanoMask and to
bring it to market as effectively and rapidly as possible."
About AlvaMed
AlvaMed was founded in 2003 to provide consultation services to medical
device companies throughout the product lifecycle. AlvaMed consultants are
not only experts in the FDA's 'rules of the road,' but have held positions
at the FDA, as well, so we know how the FDA works--from the inside. Our
solid relationships with FDA personnel are combined with comprehensive
knowledge of evolving FDA regulations and experience responding to
compliance issues--well within tight time frames.
www.alvamed.com
About Nano Mask, Inc.
http://nanomaskinc.com/
Nano Mask, Inc. is the inventor of the NanoMask, a disposable
anti-microbial facemask currently under development in partnership with
Intrinsiq Materials USA, Inc. of Menlo Park, California.
Forward-looking Statement
This release may contain statements that are forward-looking. Such
statements are made based upon current expectations that are subject to
risk and uncertainty. Specifically, the estimated testing period for the
NanoMask may need to be adjusted and extended depending on unforeseen
circumstances. Any delays may affect the planned timeline for initiating
production, registration and actual sales of the product. NMI does not
undertake to update forward-looking statements in this news release to
reflect actual results of and changes in assumptions or changes in other
factors affecting such forward-looking information. The actual future
plans and results of the company could differ significantly from such
forward-looking statements.
Contact:
Doug Heath
President and CEO
Nano Mask, Inc.
708 D Industrial Park Drive
Manteca, CA 95337
info@nanomaskinc.com
Copyright 2009, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters